Medicenna Therapeutics Corp. (TSX: MDNA)
Canada
· Delayed Price · Currency is CAD
2.470
-0.300 (-10.83%)
May 10, 2024, 4:00 PM EDT
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of 162.69 million as of May 10, 2024.
Market Cap
162.69M
Enterprise Value
140.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.47
Market Cap Chart
Since March 31, 2016, Medicenna Therapeutics's market cap has increased from 43.19M to 162.69M, an increase of 276.69%. That is a compound annual growth rate of 17.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 10, 2024 | 162.69M | 185.58% |
Mar 31, 2023 | 56.97M | -36.40% |
Mar 31, 2022 | 89.57M | -64.70% |
Mar 31, 2021 | 253.77M | 120.98% |
Mar 31, 2020 | 114.84M | 488.55% |
Mar 31, 2019 | 19.51M | -60.75% |
Mar 31, 2018 | 49.71M | -2.02% |
Mar 31, 2017 | 50.74M | 17.48% |
Mar 31, 2016 | 43.19M | 102,438.71% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bausch + Lomb Corporation | 7.41B |
Bausch Health Companies Inc. | 3.46B |
Tilray Brands, Inc. | 2.14B |
Canopy Growth Corporation | 1.13B |
Sienna Senior Living Inc. | 1.10B |
WELL Health Technologies Corp. | 962.86M |
Extendicare Inc. | 638.66M |
Knight Therapeutics Inc. | 596.90M |